Citations

Clear

7552 citation(s) found for "Ho, Matthew".

Cochlear Implant Failure after Stereotactic Radiosurgery for Vestibular Schwannoma in a Patient with Crest Syndrome
May, Matthew M. , Link, Michael J. , Carlson, Matthew L.

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | March 6, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1055/s-0039-1679713 Get It

The M1 Subtype Predominates among Infiltrating Tumor-Associated Macrophages in Phenotypically Aggressive Vestibular Schwannoma
Perry, Avital , Graffeo, Christopher S. , Driscoll, Colin L. W., Neff, Brian, Carlson, Matthew L. , Link, Michael , Carlstrom, Lucas P. , Raghunathan, Aditya , Neff, Brian A., Gompel, Jamie J. Van

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | March 6, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1055/s-0039-1679580 Get It

Abstract P243: Impact of Menopausal Hormone Therapy on Association Between Heart Fat and Carotid Artery Atherosclerosis Progression in Recently Postmenopausal Women: the KEEPS Trial
Venugopal, Vidya, Black, Dennis M. , HARMAN, MITCHELL S., Hodids, Howard N, Miller, Virginia M. , Taylor, Hugh S. , Budoff, Matthew J. , Budoff, Matthew , Khoudary, Samar R. El , Manson, JoAnn E. , Brooks, Maria M. , Santoro, Nanette F. , Brinton, Eliot A.

Mayo Clinic

Circulation | March 6, 2019 | Volume: 139 | Issue: Suppl_1 | Pages: No page available

10.1161/circ.139.suppl_1.p243 Get It

Objective: Heart fat depots, within [epicardial adipose tissue (EAT)] and outside [paracardial adipose tissue (PAT)] the pericardium, have been linked to carotid atherosclerosis in various populations. Postmenopausal women have greater volumes of heart fat than premenopausal women. Our previous work suggests that lower endogenous estrogen may contribute to heart fat accumulation, although possibly limited to PAT, while postmenopausal oral hormone therapy (HT) may slow its progression. We evaluated the effect modification of HT use over 48 months on associations between heart fat accumulation and carotid artery intima-media thickness (CIMT) progression in recently postmenopausal women. Methods: The Kronos Early Estrogen Prevention Study (KEEPS) was a multi-center, randomized, double-blind placebo-controlled trial to investigate effects over 48 months of oral conjugated equine estrogens (o-CEE) and transdermal 17β-estradiol (t-E2), both given with cyclic progesterone, compared to placebo, on progression of CIMT in recently postmenopausal women. EAT and PAT volumes, and CIMT were measured at baseline and at 48 months. Associations between the absolute changes in heart fat volumes and CIMT as well as effect modification by HT type were tested using linear regression, adjusting for age, race, study site, employment status, diastolic and systolic blood pressure, anti-hypertensive medications, insulin resistance index, lipids, body-mass index, smoking, alcohol consumption, C-reactive protein, and adipokines. Results: Of 727 randomly assigned women, 467 [mean age (SD): 52.7(2.5); 78.2% Caucasian] had heart fat volumes and CIMT measured at both time points. Overall, changes in EAT and PAT were not associated with CIMT progression; however, assigned treatment significantly modified the association between changes in PAT, but not EAT, and CIMT progression in unadjusted model, P=0.04. In o-CEE group, CIMT progression was 0.028mm (SE:0.01mm) lower, per 1 unit increase in log PAT, than in t-E2 group, P=0.01, and trended 0.017mm (SE:0.01mm) lower than in placebo group, P=0.09. Although adjusted analysis attenuated these findings (P-value for interaction 0.09), differences between o-CEE and t-E2 groups remained significant, P=0.03. Conclusion: HT use modified the association between PAT accumulation, but not EAT, and CIMT progression. Our results suggest a potential beneficial impact of o-CEE (but not transdermal E2) on the relationship between adverse changes in PAT and CIMT. The current findings support the notion that EAT and PAT are distinct fat depots and suggest a complex role of HT in the association between heart fat and CIMT progression in recently postmenopausal women.
Skull Base Manifestations of Erdheim-Chester Disease: A Case Series and Systematic Review
Peters, Pierce A., Marinelli, John P. , Lane, John I. , Carlson, Matthew L. , Vaglio, Augusto , Gompel, Jamie J. Van

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | March 6, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1055/s-0039-1679640 Get It

Influence of Selection Bias in Survey Studies Derived from a Patient-Focused Organization: A Comparison of Response Data from a Single Tertiary Care Center and the Acoustic Neuroma Association
Prummer, Christoph M., Kerezoudis, Panagiotis , Peris‐Celda, Maria , Tombers, Nicole M. , Link, Michael, Carlson, Matthew J. , Link, Michael, Carlson, Matthew

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | March 6, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1055/s-0039-1679631 Get It

Stereotactic Radiosurgery for Glomus Jugulare Tumors: Long-Term Tumor Control Using 3D Volumetric Tumor Analysis
Patel, Neil V. , Carlson, Matthew L. , Pollock, Bruce E. , Driscoll, Colin L. W., Neff, Brian, Foote, Robert L. , Lohse, Christine M. , Link, Michael P., Neff, Brian A., Link, Michael

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | March 6, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1055/s-0039-1679516 Get It

Does a Period of Observation before Treatment Lead to Worse Quality of Life in Vestibular Schwannoma Patients?
Link, Michael J. , Lohse, Christine M. , Castner, Marina L., Tombers, Nicole M. , Celda, María Peris, Driscoll, Colin L. W., Carlson, Matthew L.

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | March 6, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1055/s-0039-1679488 Get It

Investigation of white matter PiB uptake as a marker of white matter integrity
Zeydan, Burcu , Schwarz, Christopher G. , Lowe, Val J. , Reid, Robert I. , Przybelski, Scott A. , Lesnick, Timothy G. , Kremers, Walter K. , Senjem, Matthew L. , Gunter, Jeffrey L. , Min, Hoon‐Ki , Vemuri, Prashanthi , Petersen, Ronald C. , Jack, Clifford R. , Kantarci, Orhun H. , Kantarci, Kejal , Min, Hoon-Ki Paul , Jack, Clifford R , Schwarz, Christopher G , Reid, Robert I , Vemuri, Prashanthi , Senjem, Matthew L , Kantarci, Kejal , Zeydan, Burcu , Kremers, Walter K , Knopman, David S.

Mayo Clinic

Annals of Clinical and Translational Neurology | March 4, 2019 | Volume: 6 | Issue: 4 | Pages: 678-688

10.1002/acn3.741 | PMID 31019992 Get It

AbstractObjectiveTo investigate the associations of Pittsburgh compound‐B (PiB) uptake in white matter hyperintensities (WMH) and normal appearing white matter (NAWM) with white matter (WM) integrity measured with DTI and cognitive function in cognitively unimpaired older adults.MethodsCognitively unimpaired older adults from the population‐based Mayo Clinic Study of Aging (n = 537, age 65–95) who underwent both PiB PET and DTI were included. The associations of WM PiB standard uptake value ratio (SUVr) with fractional anisotropy (FA) and mean diffusivity (MD) in the WMH and NAWM were tested after adjusting for age. The associations of PiB SUVr with cognitive function z‐scores were tested after adjusting for age and global cortical PiB SUVr.ResultsThe WMH PiB SUVr was lower than NAWM PiB SUVr (P < 0.001). In the WMH, lower PiB SUVr correlated with lower FA (r = 0.21, P < 0.001), and higher MD (r = −0.31, P < 0.001). In the NAWM, lower PiB SUVr only correlated with higher MD (r = −0.10, P = 0.02). Both in the WMH and NAWM, lower PiB SUVr was associated with lower memory, language, and global cognitive function z‐scores after adjusting for age and global cortical PiB SUVr.InterpretationReduced PiB uptake in the WMH is associated with a loss of WM integrity and cognitive function after accounting for the global cortical PiB uptake, suggesting that WM PiB uptake may be an early biomarker of WM integrity that precedes cognitive impairment in older adults. When using WM as a reference region in cross‐sectional analysis of PiB SUVr, individual variability in WMH volume as well as age should be considered.
For Whom the Bell's Toll: Recurrent Facial Nerve Paralysis, A Retrospective Study and Systematic Review of the Literature
Chweya, Cynthia M. , Anzalone, C. Lane , Driscoll, Colin L. W., Lane, John I. , Carlson, Matthew L.

Mayo Clinic

Otology & Neurotology | March 2, 2019 | Volume: 40 | Issue: 4 | Pages: 517-528

10.1097/mao.0000000000002167 | PMID 30870370 Get It

Purpose: To examine the etiology, clinical course, and management of recurrent peripheral facial nerve paralysis. Methods: Retrospective review at a single tertiary academic center and systematic review of the literature. Clinical presentation, laboratory and imaging findings, treatment and outcome for all cases of recurrent ipsilateral, recurrent contralateral, and bilateral simultaneous cases of facial paralysis are reviewed. Results: Between 2000 and 2017, 53 patients [41.5% men, 29 median age of onset (range 2.5 wk–75 yr)] were evaluated for recurrent facial nerve paralysis at the authors’ institution. Twenty-two (41.5%) cases presented with ipsilateral recurrences only, while the remaining 31 patients (58.5%) had at least 1 episode of contralateral recurrent paralysis. No cases of bilateral simultaneous facial nerve paralysis were observed. The median number of paretic events for all patients was 3 (range 2–20). The median nadir House–Brackmann score was 4, with a median recovery to House–Brackmann grade 1.5 over a mean recovery time of 61.8 days (range 1–420 d). Diagnostic evaluation confirmed Melkersson–Rosenthal syndrome in four (7.5%) cases, neurosarcoidosis in two (3.7%), traumatic neuroma in one (1.9%), Ramsay Hunt syndrome in one (1.9%), granulomatosis with polyangiitis in one (1.9%), and neoplastic causes in three (5.7%) cases [facial nerve schwannoma (n = 2; 3.7%), metastatic squamous cell carcinoma to the deep lobe of the parotid gland (n = 1; 1.9%)]; ultimately, 77.4% (41) of cases were deemed idiopathic. Facial nerve decompression via a middle cranial fossa approach was performed in three (5.7%) cases without subsequent episodes of paralysis. Conclusion: Recurrent facial nerve paralysis is uncommon and few studies have evaluated this unique population. Recurrent ipsilateral and contralateral episodes are most commonly attributed to idiopathic facial nerve paralysis (i.e., Bell's palsy); however, a subset harbor neoplastic causes or local manifestations of underlying systemic disease. A comprehensive diagnostic evaluation is warranted in patients presenting with recurrent facial nerve paralysis and therapeutic considerations including facial nerve decompression can be considered in select cases.
Intralabyrinthine Schwannomas: Disease Presentation, Tumor Management, and Hearing Rehabilitation
Choudhury, Baishakhi, Carlson, Matthew L. , Jethanamest, Daniel

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | March 2, 2019 | Volume: 80 | Issue: 02 | Pages: 196-202

10.1055/s-0039-1678731 | PMID 30931228 Get It

AbstractIntralabyrinthine schwannomas (ILS) are rare tumors that frequently cause sensorineural hearing loss. The development and increased use of magnetic resonance imaging in recent years have facilitated the diagnosis of these tumors that present with otherwise nondiscriminant symptoms such as tinnitus, vertigo, and hearing loss. The following is a review of the presentation, pathophysiology, imaging, and treatment with a focused discussion on auditory rehabilitation options of ILS.